Post #4046353

The products are popular with a group of unlikely allies, including the “looksmaxxing” and fitness communities, longevity experts, dermatologists and medical spas, and companies that operate compounding pharmacies like Noom and Hims & Hers Health, both of which made a name selling GLP-1 medications, which are also peptides. Hims’ stock rallied 10% after the BPC-157 vote. https://www.msn.com/en-us/money/general/most-fda-advisers-say-the-bpc-157-and-kpv-peptides-should-be-made-available-in-the-us-here-s-what-happens-next/ar-AA28xfVz